Fillable Printable Phs 398/2590, Other Support Format Page
Fillable Printable Phs 398/2590, Other Support Format Page
Phs 398/2590, Other Support Format Page
Program Director/Principal Investigator:
(Last, first, middle)
PHS 398/2590 (Rev. 06/09) Page ____ Other Support Format Page
For New and Renewal Applications (PHS 398) – DO NOT SUBMIT UNLESS REQUESTED
For Non-competing Progress Reports (PHS 2590) – Submit only Active Support for Key Personnel
PHS 398/2590 OTHER SUPPORT
Provide active support for all key personnel. Other Support inclu
des all financial resources, whether Federal, non-Federal, commercial or
institutional, available in direct support of an individual's research endeavors, including but not limited to research grants, cooperative
agreements, contracts, and/or institutional awards. Training awards, prizes, or gifts do not need to be included.
There is no "form page" for other support. Information on other support should be pro
vided in the format shown below, using continuation pages as
necessary. Include the principal investi gator's name at the top and number consecutively with the rest of the application. The sample below is
intended to provide guidance regarding the type and extent of information requested.
For instructions and information pertaining to the use of and policy for other support, see Other Suppo
rt in the PHS 398 Part III, Policies, Assurances,
Definitions, and Other Information.
Note effort devoted to projects must now be measured using person months. Indicate calendar, academic, and/or sum
mer months associated with each
project.
Format
NAME OF INDIVIDUAL
ACTIVE
/PENDING
Project Number (Principal Investigator)
Source
Title of Project (or Subp
roject)
The major goals of this p
roject are…
Dates of Approved/Proposed Project
Annual Direct Costs
Person Months
(Cal/Academic/
Summer)
OVERLAP (summarized for each individ ual)
Samples
ANDERSON, R.R.
ACTIVE
2 R01 HL 00000-13 (Anderson) 3/1/1997 – 2/28/2002 3.60 calendar
NIH/NHLBI $186,529
Chloride and Sodium Transport in Airway Epithelial Cells
The major goals of this project are to define the biochemistry of chloride and sodium transport in airway
epithelial
cells and clone
the gene(s)
involved in transport.
5 R01 HL 00000-07 (Baker)
4/1/1994 – 3/31/2002 1.20 calendar
NIH/NHLBI $122,717
Ion Transport in Lungs
The major goal of this project is to study chloride and sodium transport in normal and diseased lungs.
R000 (Anderson) 9/1/1996 – 8/31/2002 1.20 calendar
Cystic Fibrosis Foundation $43,123
Gene Transfer of CFTR to the Airway Epithelium
The major goals of this project are to identify and isolate airway epithelium progenitor cells and express
human CFT
R in airway epithelial cells.
PENDI
NG
DCB 950000 (Anderson) 12/01/2002 – 11/30/2004 2.40 calendar
National Science Foundation $82,163
Liposome Membrane Composition and Function
The major goals of this project are to define biochemical properties of liposome membrane components
and maximize liposome uptake into cells.
Program Director/Principal Investigator:
(Last, first, middle)
PHS 398/2590 (Rev. 06/09) Page ___ Other Support Format Page
OVERLAP
There is scientific overlap between aim 2 of NSF DCB 950000 and aim 4 of the application under
consideration. If both are funded, th
e budgets will be adjusted appropriately in conjunction with agency
staff.
RICHARDS, L.
NONE
HERNANDEZ, M.
ACTIVE
5 R01 CA 00000-07 (Hernandez) 4/1/1995 – 3/31/2002 3.60 academic
NIH/NCI $110,532
Gene Therapy for Small Cell Lung Carcinoma
The major goals of this project are to use viral strategies to express the normal p53 gene in human SCLC
cell lines an
d to study the effect on g
r
owth and invasiveness of the lines.
5 P01 CA 0
0000-03 (Chen) 7/1/2000 – 6/30/2002 1.80 academic
NIH/NCI $104,428 (sub only) 3.00 summer
Mutations in p53 in Progression of Small Cell Lung Carcinoma
The major goals of this subproject are to define the p53 mutations in SCLC and their contribution to tumor
progression and
metastasis.
BE 00000 (Hernandez)
9/1/1996 – 8/31/2002 1.80 academic
American Cancer Society $86,732
p53 Mutations in Breast Cancer
The major goals of this project are to define the spectrum of p53 mutations in human breast cancer
samples an
d correlate the results with clinical outcome.
OVERLAP
Potential commitment overlap for Dr. Hernandez between 5 R01 CA 00000-07 and the application under
consideration. If the application under consideration is funded with Dr. Hernandez committed at 3.60
person months, Dr. Hernandez will re
quest approval to reduce her months on the NCI grant.
BENNETT, P.
ACTIVE
Investigator Award (Bennett) 9/1/1999 – 8/31/2002 9.00 calendar
Howard Hughes Medical Institute $581,317
Gene Cloning and Targeting for Neurological Disease Genes
This award supports the PI’s program to map and clone the gene(s) implicated in the development of
Alzheimer’s
disease and
to target expression of t
he cloned g
ene(s) to relevant cells.
OVE
RLAP
: None
